Each year, the CTO Conference provides a forum to drive innovation in clinical trials, engaging a wide group of stakeholders across the clinical trial landscape, including leaders from the pharmaceutical and medical device industries, academic and healthcare leaders, representatives from patient groups, health charities and research institutions.

More sessions and speakers to be announced! 

Stay tuned for further details about CTO’s agenda here and follow us on Twitter for updates at @clinicaltrialON!

Registration

November 6 & 7
7:30am – 8:45am

Join us in the morning to pick up your badge, enjoy some breakfast and explore the Innovation Showcase before the plenary sessions begin. 

Morning Sessions

November 6

Welcome Remarks

  • Susan Marlin, President and CEO, Clinical Trials Ontario
  • Rapheal Hofstein, Chair, Clinical Trials Ontario Board of Directors

KEYNOTE: The Precision Patient: My experience with rare cancer and clinical trials

  • Allen Chankowsky, Acclaimed Author, International Speaker, and resilient 33-year survivor of a rare form of stage-4 Androgen Receptor positive cancer

Charting a Path Forward: Strategies to Advance Clinical Trials and Life Sciences

With presentations from:

  • Dr. PJ Devereaux, Director, Division of Perioperative Care, and Professor, Departments of Health Research Methods, Evidence, and Impact and Medicine, McMaster University; Associate Deputy Director and Senior Scientist, Population Health Research Institutes
  • Dr. Bradly Wouters, Executive Vice President, Science and Research, University Health Network
  • Dr. Jason Field, President and CEO of Life Sciences Ontario

Community Hospitals: Essential Contributors to Ontario’s Evolving Clinical Trials Networks 

Afternoon Sessions

November 6

Reducing Barriers: Equity and Diversity in Clinical Trials

  • Moderator: Michelle Audoin, Patient and Family Advisory Council, Ontario Institute of Cancer Research

New immigrant participation in clinical trials

  • Munaza Jamil, Chair, N2 Public Engagement Committee; Lead, Monitoring Program at MICYRN

Compensation in Clinical Trials

  • Dr. Stuart Nicholls, Strategy for Patient-Oriented Research Program Facilitator, Office for Patient Engagement in Research Activities (OPERA), The Ottawa Hospital Research Institute’s Methods Centre

Language Matters: Expanding Access by Enhancing Translation Services

  • Dr. Quynh Doan, Senior Executive Director, Associate Dean, Research, Congdon Family Hospital Chair in Research at BC Children’s Hospital, Clinician Scientist, Pediatric Emergency Medicine

KEYNOTE: Live Sickboy Podcast! Groundbreaking trials, life saving medicine

  • Sickboy, North America’s Revolutionary Voice in Health and Wellness
  • Dr. Nir Lipsman, Neurosurgeon and Senior Scientist, Sunnybrook Research Institute and Sunnybrook Health Sciences Centre; Associate Professor, Department of Surgery, University of Toronto

Reception

November 6
5:00pm – 7:00pm

CTO 2024 Reception

Join us in celebrating the achievements of our clinical trials community over the past year.

Thank you to our 2024 Reception Sponsor GNMI Medical Imaging.

Morning Sessions

November 7

Health Data, AI and the Changing Landscape of Clinical Trials

Clinical Trials at the Canadian Institutes of Health Research

  • Dr. Megan Bettle, Executive Director, Clinical Trials, Canadian Institutes of Health Research

What Keeps REBs Up At Night?

  • Sharon Freitag, Senior Director, Research Ethics, Unity Health Toronto
  • Natascha Kozlowski, Executive Director, Ontario Cancer Research Ethics Board (OCREB)
  • Meera Sidhu, Research Ethics Manager, Vice Principal Research, Research Ethics Compliance, Queen’s University
  • Elizabeth Lylyk, Director, RITHIM, Research Manitoba

Afternoon Sessions

November 7

KEYNOTE: What Does Indigenous Cultural Safety Have to Do With ME?

  • Dr. Janet Smylie, Family Physician and Research Scientist, Unity Health Toronto; Professor, University of Toronto (Dalla Lana School of Public Health and Department of Family and Community Medicine); Tier 1 Canada Research Chair in Advancing Generative Health Services for Indigenous Populations in Canada

Canadians Want More Options for Decentralized and Hybridized Clinical Trials

One Year Later: Progress Report on Advanced Consent in Stroke Trials

  • Michel Shamy MD MA FRCPC, Attending Neurologist, The Ottawa Hospital; Scientist, Ottawa Hospital Research Institute; Associate Professor, Departments of Medicine & Epidemiology, University of Ottawa; Lead, Ethics & Humanities in Medicine, University of Ottawa
Attendance at our conference may be eligible for SOCRA continuing education credits. All conference delegates may request a certificate of attendance.